SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Value Investing -- Ignore unavailable to you. Want to Upgrade?


To: Elroy who wrote (71250)10/3/2022 1:21:03 PM
From: E_K_S  Respond to of 78652
 
Re: BGS

I believe (from memory) their last refinance was out to 2023-2024 and they have been using their credit facility to carry them through to Q4 when price increases kick in. Not a good combination of large debt and rising interest rates w/o too much pricing power.

At this point in the cycle (and sell off in other stocks), BGS is not too compelling except for their dividend. LUMN offers a larger div yield and in a different sector. They called a bunch of their bonds and are reducing debt.

I did add a few LUMN last week at $7.25/share and more at $8.02/share.

FWIW, I see I have some BGS Buys in 2/2020 at/near $13/share and more in 11/2019 at $12.85/share and my best BUY 2/25/2020 at $10.90/share. Currently my average cost for BGS is $19.78/share and no plans to buy more unless I get at $12/share



To: Elroy who wrote (71250)11/10/2022 8:17:12 PM
From: E_K_S  Read Replies (1) | Respond to of 78652
 
B&G Foods (BGS) Q3 Earnings In Line With Estimates, Sales Miss

B&G Foods, Inc. BGS reported mixed third-quarter fiscal 2022 numbers, wherein the bottom line was in line with the Zacks Consensus Estimate, while sales missed the same. Meanwhile, earnings declined year over year and sales improved. The company benefited from higher demand and pricing, offset by increased input cost inflation and continued supply-chain headwinds.

Management reiterated its net sales guidance for fiscal 2022, while lowering its view for adjusted EBITDA and the bottom line due to cost inflation.
Net sales of $528.4 million increased 2.6% year over year mainly due to pricing gains and a favorable product mix. This was somewhat offset by soft volumes stemming from supply-chain hurdles and price elasticity. The top line missed the Zacks Consensus Estimate of $531 million and our estimate of $537 million.

Base business net sales advanced 2.5% to $527.5 million, owing to net pricing gains and a favorable product mix. These were partially countered by a fall in the unit volume and currency headwinds.
Net sales of Crisco, Cream of Wheat, Clabber Girl and Ortega rose 38.3%, 20.4%, 26.6% and 2.6%, respectively. However, net sales of Green Giant (including Le Sueur), Maple Grove Farms and spices & seasonings declined by 12.6%, 2.9% and 6.5%, respectively. Base net sales of all the other brands in the aggregate rose 0.5%.
The company expects the input cost inflation to bear a significant impact industry-wide for the remainder of fiscal 2022 and in fiscal 2023. BGS is on track to mitigate the impacts of inflation on the gross margin by undertaking cost-saving initiatives, increasing list prices, and locking in prices via short-term supply contracts and advance commodities purchase agreements. Nonetheless, these actions may not fully offset the supplementary cost headwinds through the rest of fiscal 2022 and beyond.
Impairment of Assets Held for Sale

In connection with the Company’s previously announced transition to a business unit structure, the Company has decided to divest its Back to Nature business, which is no longer core to the Company’s overall business or long-term strategy. The Company is actively seeking to sell the Back to Nature business. As a result, the Company reclassified $109.9 million of indefinite-lived trademark intangible assets, $29.5 million of goodwill, $11.0 million of finite-lived customer relationship intangible assets and $7.4 million of inventories to assets held for sale. The Company then measured the assets held for sale at the lower of their carrying value or fair value less anticipated costs to sell and recorded pre-tax, non-cash impairment charges of $103.6 million during the third quarter of 2022.


--------------------------------------------------------------------------------------

Shares traded as low as $12.29/share and as high as $16.03/share and closed at $15.08/share +2.94%.

FWIW I had 4 different Buys today at $12.67, $12.87, $13.27 & $13.47; mostly w/ GTC orders that filled. Total Buys represented a 15% add to my current holdings representing a 2.8% portfolio position.

The company is planning to sell their non-core "Back To Nature" business and wrote down some intangible assets and trademarks. They said they plan to increase product prices and consolidate some warehouse/distribution assets to be more efficient.

Price/Cash Flow still quite attractive at 3.97x and the 2023 Forward PE (adjusted) will now be around 15x and may/could be lower toward the 2nd half of 2023.